Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | -0.66 | -6.01 | -10.40 | -10.43 |
Depreciation/ Depletion | 0.09 | 4.95 | 9.92 | 9.91 |
Non- Cash Items | -0.05 | 0.01 | 0.05 | 0.09 |
Changesin Working Capital | 0.61 | 1.05 | 0.52 | 0.45 |
Cashfrom Operating Activities | 0.00 | 0.00 | 0.10 | 0.01 |
Other Investing Cash Flow Items Total | 0.00 | 0.00 | -0.10 | - |
Cashfrom Investing Activities | 0.00 | -0.01 | -0.10 | -0.03 |
Financing Cash Flow Items | 0.00 | - | - | - |
Cashfrom Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
Net Changein Cash | 0.00 | -0.01 | 0.00 | -0.01 |
Capital Expenditures | - | -0.01 | 0.00 | -0.03 |
Issuance( Retirement)of Debt Net | - | 0.00 | 0.00 | - |
Issuance( Retirement)of Stock Net | - | - | - | 0.00 |
Transgene Biotek Dividend Transgene Biotek Bonus Transgene Biotek News Transgene Biotek AGM Transgene Biotek Rights Transgene Biotek Splits Transgene Biotek Board Meetings Transgene Biotek Key Metrics Transgene Biotek Shareholdings Transgene Biotek Profit Loss Transgene Biotek Balance Sheet Transgene Biotek Q1 Results Transgene Biotek Q2 Results Transgene Biotek Q3 Results Transgene Biotek Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks